Cetuximab Completed Phase 1 Trials for Colorectal Cancers / Lung Cancer Non-Small Cell Cancer (NSCLC) / Head and Neck Carcinoma

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT00820417Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib